Search Tag: #ESCcongress
#ESCCongress: BRACE CORONA Trial and Safety of Heart Drugs
2020 01 Sep
Heart patients hospitalised with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020. ACE inhibitors and ARBs are commonly taken by heart patients to reduce blood pressure and to... Read more
#ESCCongress: Findings from DAPA-CKD Trial
2020 30 Aug
The main results of the DAPA-CK trial were presented today at ESC Congress 2020. Findings showed that dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failure hospitalisation and all-cause mortality in chronic kidney disease patients with or without type 2 diabetes. The goal of the DAPA-CKD trial was to... Read more
#ESCCongress: Results from the EXPLORER-HCM Trial
2020 30 Aug
New findings presented at the ESC Congress show that mavacemten improves heart function and symptoms in patients with obstructive hypertrophic cardiomyopathy (HCM). To date, the medical treatments for obstructive HCM focus on symptom relief but do not address the underlying causes. These treatments also offer modest efficacy with significant... Read more
#ESCCongress: EMPEROR-Reduced Trial Meets Primary Endpoint
2020 29 Aug
In a Hot Line session today at ESC Congress 2020, findings from the EMPEROR-Reduced trial showed that empagiflozin reduces the risk of cardiovascular death or hospitalisation for heart failure in patients with heart failure and a reduced ejection fraction. The findings are published in the New England Journal of Medicine. The clinical trial evaluated... Read more
#ESCCongress: Vaccines Against Respiratory Infections Reduce Heart Failure Deaths
2020 29 Aug
According to new findings presented at the ESC Congress 2020, influenza and pneumonia vaccinations are associated with fewer hospital deaths in heart failure patients. Approximately 26 million people are affected with heart failure worldwide. It is estimated that one out of five individuals will develop heart failure in their lifetime. Heart failure... Read more
#ESCCongress 2020 Moves 100% Online
2020 07 May
ESC Congress – the world’s largest cardiovascular event – moves 100% online for the first time in its 70-year history, to create ESC Congress 2020 – Challenging Times, Infinite Possibilities. Mark your calendars now and join the Congress online from Saturday, 29 August to Tuesday, 1 September. The decision by the European Society of Cardiology... Read more
Top Cardiology Stories of 2019
2019 27 Dec
As we move into 2020, here's a quick recap of our most clicked stories in Cardiology in 2019: ORION-10 Trial: Inclisiran Effective at Reducing LDL Findings from the ORION-10 trial presented at the AHA Scientific Session in 2019 showed that twice-yearly injections of inclisiran were effective at reducing LDL cholesterol. ENCOURAGE... Read more
New Management Pathways in Cardiovascular Risk Factors
2019 02 Oct
Summary: A presentation of a case study in light of the updated ESC guidelines on lipid control and new guidelines on diabetes and cardiovascular disease. Several new guidelines were released at the European Society of Cardiology (ESC) Congress in Paris, France. These included updated guidelines on lipid control and new guidelines... Read more
#ESCCongress: Artificial Intelligence for Heart Attack Prediction
2019 04 Sep
New findings presented at the ESC Congress in Paris demonstrated technology that uses artificial intelligence (AI) to identify people at high risk of a fatal heart attack at least five years before it strikes. These findings are published in the European Heart Journal. The technology has been developed by researchers at the University of Oxford.... Read more
#ESCCongress: New Management Pathways in Cardiovascular Risk Factors
2019 03 Sep
At the ESC Congress this year, several new guidelines have been released including updated guidelines on lipid control and new guidelines on diabetes and cardiovascular disease. As per the updated guidelines on lipid control , the following are some key recommendations: Low-density lipoprotein (LDL) cholesterol levels should be lowered... Read more